Development and Validation of Bioanalytical Method for The Determination of Valcyclovir HCl in Human Plasma by Liquid Chromatoghraphy
 
More details
Hide details
1
Jawaharlal Nehru Technological University, Hyderabad, Amrutvahini College of Pharmacy, Sangamner, Sp Pune University, Pune
CORRESPONDING AUTHOR
Mahesh Mukund Deshpande   

Jawaharlal Nehru Technological University, Hyderabad, Amrutvahini College of Pharmacy, Sangamner, Sp Pune University, Pune
Publish date: 2017-10-05
 
Eurasian J Anal Chem 2015;10(2):106–112
KEYWORDS
ABSTRACT
Valacyclovir hydrochloride (2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl) methoxyl]ethyl ester-l-valine monohydrochloride), is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) to prevent genital herpes outbreaks in adults infected with HIV.A simple method is described for the quantitation of Valcyclovir HCl in plasma by liquid chromatography. Chromatographic separation was achieved on a reversed phase Hypersil ODS C18 (150mm * 4.6mm, 5.0μm) column, using isocratic elution (acetonitrile-water (85:15) at a flow rate of 0.2–1.2 ml/min. Valacyclovir hydrochloride were measured using UV detection at 265 nm. The total chromatographic run-time was 10 min with Valacyclovir hydrochloride eluting at 4.19 min. Limit of quantification was 50ng/ml. The linearity range of the method was 50-2000 ng/ml (r2 = 0.9987). Mean recoveries from plasma were 105.13%. Intra-batch and inter-batch precision was 0.857 and 0.842, respectively. The Freeze and Thaw Stability, Short-Term Temperature Stability , Long-Term Stability, Stock Solution Stability evaluation indicated no evidence of degradation of Valacyclovir hydrochloride. The validated method is simple, selective and rapid and can be used for pharmacokinetic study.
 
REFERENCES (9)
1.
United States Pharmacopeia, National Formulary-29, Rockville, USA: United States Pharmacopeial convention; 2011.
 
2.
Maryadele J, The Merck Index, In: O'Neil, editor. 13th ed. Whitehouse Station, NJ, USA: The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, 2001, 9966.
 
3.
Martindale, the Extra Pharmacopoeia, Published by direction of the Council of Royal Pharmaceutical Society of Great Britain, 34th ed. Vol. 11. London Royal Pharmaceutical Society, 1996, 2005, 653,656.
 
4.
Kasiari M, Gikas E, Kazanis M, Panderi I, Journal of Chromatography B, 864(1–2), 2008, 78-86.
 
5.
Heon-Woo L, Ji-Hyung Seo, Kyung-Tae Lee, Journal of Chromatography B, 852(1–2), 2007, 382-388.
 
6.
Sasanya JJ, Abd-Alla AM, Parker AG, Cannavan A, Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 878(26), 2010, 2384- 2390.
 
7.
International Conference on Harmonisation, Validation of analytical procedures: Text and methodology, In ICH Harmonized Tripartite Guidelines Q2 (R1), November 2005.
 
8.
Surendra Bansal and Anthony DeStefano , The AAPS Journal 2007; 9 (1).
 
9.
Henning Blumea,c, Erich Brendelb Margarete Brudny-Klöppelb, Sylvia Grebec, Berthold Lauseckerd, Gabriele Rohdeb, Christoph Siethoff, European Journal ofPharmaceutical Sciences 42 (2011) 300–305.
 
eISSN:1306-3057